<DOC>
	<DOCNO>NCT00449956</DOCNO>
	<brief_summary>The clinical study compare safety efficacy MK0507A ( dorzolamide 1.0 % / timolol 0.5 % ) 1 ) timolol 0.5 % 2 ) concomitant therapy dorzolamide 1.0 % / timolol 0.5 % patient glaucoma ocular hypertension .</brief_summary>
	<brief_title>MK0507A Clinical Study Patients With Glaucoma Ocular Hypertension ( 0507A-149 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>Patients glaucoma ocular hypertension History ocular surgery within 3 month Administration contradiction timolol dorzolamide</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>